SDI Group Regulatory News (SDI)

SCIENTIFIC DIGITAL IMAGING PLC

("SDI" or the "Company") 

Director Dealing

Scientific Digital Imaging plc (AIM: SDI), the AIM quoted group focused on the application of digital imaging technology for use in life sciences, healthcare, astronomy, and art conservation, announces that Mike Creedon, Chief Executive of the Company, has today subscribed for 62,500 Ordinary Shares at a price of 8 pence per Ordinary Share as part of the previously announced Equity Fundraising. The Equity Fundraising is conditional, inter alia, on shareholder approval of certain resolutions to be proposed at the General Meeting.

Upon completion of the Equity Fundraising, Mike Creedon will be interested in an aggregate of 70,000 Ordinary Shares, representing approximately 0.1 per cent. of the Company's issued share capital, as enlarged by the Equity Fundraising.

All capitalised but undefined terms in this announcement shall have the meaning ascribed to them in the Circular sent to shareholders in relation to, inter alia, the Equity Fundraising.

For Further Information:

Note to Editors:

About Scientific Digital Imaging plc

Scientific Digital Imaging plc designs, manufactures and sells digital imaging technology for use in the life sciences, healthcare, astronomy, and art conservation through Synoptics brands (Syngene, Synoptics Health, Synbiosis and Syncroscopy), the Artemis CCD company brands (Atik Cameras and Artemis CCD Cameras) and the Opus Instruments brand (Osiris). SDI plans to continue to grow through its own technology advancements as well as strategic, complementary acquisitions.

www.scientificdigitalimaging.com